SignalEU/UK

AstraZeneca made a $10B offer for Rhythm Pharmaceuticals. That is a big strategic bid and gives $RYTM holders a clear takeover print to trade against. $AZN $RYTM

AstraZeneca's $10 billion acquisition offer for Rhythm Pharmaceuticals signals major pharma M&A activity.

RYTM

$115.02

+4.70%

AZN

$184.45

+0.04%

What changed

AstraZeneca's $10 billion acquisition offer for Rhythm Pharmaceuticals signals major pharma M&A activity.

Why it matters

AstraZeneca's $10 billion acquisition offer for Rhythm Pharmaceuticals signals major pharma M&A activity. — impact context not separately stored; see What changed.

Sources

wsj